L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase.

  title={L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase.},
  author={Rob Pieters and Stephen P Hunger and Joachim Boos and Carmelo Rizzari and Lewis B. Silverman and Andr{\'e} Baruchel and Nicola Goekbuget and Martin Schrappe and Ching-Hon Pui},
  volume={117 2},
Asparaginases are a cornerstone of treatment protocols for acute lymphoblastic leukemia (ALL) and are used for remission induction and intensification treatment in all pediatric regimens and in the majority of adult treatment protocols. Extensive clinical data have shown that intensive asparaginase treatment improves clinical outcomes in childhood ALL. Three asparaginase preparations are available: the native asparaginase derived from Escherichia coli (E. coli asparaginase), a pegylated form of… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 126 extracted citations


Publications referenced by this paper.
Showing 1-10 of 70 references

Biology and treatment of acute lymphoblastic leukemia.

Hematology/oncology clinics of North America • 2010

Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2009

PEG-asparaginase in adult acute lymphoblastic leukemia (ALL): efficacy and feasibility analysis with increasing dose levels

N Goekbuget, A Baumann, +3 authors H Diedrich

Similar Papers

Loading similar papers…